[Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
D000368:Aged; D001786:Blood Glucose; D001835:Body Weight; D001892:Camphanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D004342:Drug Hypersensitivity; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014044:Tolbutamide / Q000627:therapeutic use
D001786:Blood Glucose; D001892:Camphanes; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005905:Glyburide
Behandlung des Erwachsenendiabetes mit Glibornurid. Ergebnisse einer klinischen Studie.